Aaron Gani, CEO and founder of RealizedCare, discusses the evolution of digital therapeutics, the FDA’s place in advancing them, keeping up with evolving technology, and the benefits of DTx modalities for the pharmaceutical industry. Global By HIMSS TV | June 14, 2024 | 4:53 PM Tags: digital therapeutics, Business Intelligence